<?xml version="1.0" encoding="UTF-8"?>
<p>Bone marrow biopsies before and after mirabegron treatment were obtained in 20 patients of the 39 patients who consented to this subproject (51%). These included 9 PV, 4 ET, 4 PMF, 2 post-ET, and 1 post-PV MF patients. The biopsies were evaluated in a blinded fashion.</p>
